Patents by Inventor Christian Alexander Röhrig

Christian Alexander Röhrig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric endolysin polypeptide, cluster 3b
    Patent number: 12226461
    Abstract: The invention relates to the field of antibacterial polypeptides, specifically to the field of antibacterial polypeptides having lytic activity for Staphylococcus. The invention relates to a novel chimeric endolysin polypeptide specifically targeting a Staphylococcus cell. The invention further relates to the use of said chimeric endolysin polypeptide as a disinfectant, as an antimicrobial cosmetic, for detection, such as in a diagnostic application and for medical use, such as for treating an individual suffering from a condition associated with a Staphylococcus infection.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: February 18, 2025
    Assignee: Micreos Pharmaceuticals AG
    Inventors: Fritz Eichenseher, Mathias Schmelcher, Christian Alexander Rohrig
  • Chimeric endolysin polypeptide
    Patent number: 12091691
    Abstract: The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
    Type: Grant
    Filed: February 21, 2024
    Date of Patent: September 17, 2024
    Assignee: Micreos Pharmaceuticals AG
    Inventors: Mathias Schmelcher, Christian Alexander Röhrig, Markus Huemer, Fritz Eichenseher
  • Chimeric endolysin polypeptide, cluster 3b
    Publication number: 20240293517
    Abstract: The invention relates to the field of antibacterial polypeptides, specifically to the field of antibacterial polypeptides having lytic activity for Staphylococcus. The invention relates to a novel chimeric endolysin polypeptide specifically targeting a Staphylococcus cell. The invention further relates to the use of said chimeric endolysin polypeptide as a disinfectant, as an antimicrobial cosmetic, for detection, such as in a diagnostic application and for medical use, such as for treating an individual suffering from a condition associated with a Staphylococcus infection.
    Type: Application
    Filed: May 10, 2023
    Publication date: September 5, 2024
    Applicant: Micreos Pharmaceuticals AG
    Inventors: Fritz EICHENSEHER, Mathias SCHMELCHER, Christian Alexander ROHRIG
  • Chimeric endolysin polypeptide
    Publication number: 20240279631
    Abstract: The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
    Type: Application
    Filed: February 21, 2024
    Publication date: August 22, 2024
    Applicant: Micreos Pharmaceuticals AG
    Inventors: Mathias Schmelcher, Christian Alexander Röhrig, Markus Huemer, Fritz Eichenseher
  • Chimeric endolysin polypeptide
    Publication number: 20240148840
    Abstract: The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
    Type: Application
    Filed: June 14, 2023
    Publication date: May 9, 2024
    Applicant: Micreos Human Health B.V.
    Inventors: Fritz Eichenseher, Mathias Schmelcher, Christian Alexander Rohrig
  • Chimeric endolysin polypeptide
    Patent number: 11834687
    Abstract: The invention relates to the field of antibacterial polypeptides, specifically to the field of antibacterial polypeptides having lytic activity for Staphylococcus. The invention relates to a novel chimeric endolysin polypeptide specifically targeting a Staphylococcus cell. The invention further relates to the use of said chimeric endolysin polypeptide as a disinfectant, as an antimicrobial cosmetic, for detection, such as in a diagnostic application and for medical use, such as for treating an individual suffering from a condition associated with a Staphylococcus infection.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: December 5, 2023
    Assignee: Micreos Pharmaceuticals AG
    Inventors: Fritz Eichenseher, Mathias Schmelcher, Christian Alexander Rohrig
  • A chimeric endolysin polypeptide
    Publication number: 20230158122
    Abstract: The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
    Type: Application
    Filed: April 16, 2021
    Publication date: May 25, 2023
    Applicant: Micreos Human Health B.V.
    Inventors: Fritz Eichenseher, Mathias Schmelcher, Christian Alexander Röhrig